Sterling Investment Counsel’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $602K | Sell |
3,245
-5,006
| -61% | -$929K | 0.35% | 50 |
|
|
2025
Q1 | $1.73M | Buy |
8,251
+4,681
| +131% | +$981K | 0.59% | 32 |
|
|
2024
Q4 | $634K | Sell |
3,570
-4,752
| -57% | -$844K | 0.42% | 40 |
|
|
2024
Q3 | $1.64M | Buy |
8,322
+1,087
| +15% | +$215K | 0.59% | 32 |
|
|
2024
Q2 | $1.24M | Buy |
7,235
+443
| +7% | +$76K | 0.49% | 38 |
|
|
2024
Q1 | $1.24M | Buy |
6,792
+490
| +8% | +$89.2K | 0.57% | 37 |
|
|
2023
Q4 | $977K | Buy |
6,302
+1,436
| +30% | +$223K | 0.5% | 40 |
|
|
2023
Q3 | $725K | Buy |
4,866
+890
| +22% | +$133K | 0.42% | 49 |
|
|
2023
Q2 | $536K | Sell |
3,976
-279
| -7% | -$37.6K | 0.29% | 61 |
|
|
2023
Q1 | $678K | Buy |
4,255
+1,499
| +54% | +$239K | 0.4% | 44 |
|
|
2022
Q4 | $445K | Buy |
2,756
+103
| +4% | +$16.6K | 0.28% | 70 |
|
|
2022
Q3 | $356K | Buy |
2,653
+387
| +17% | +$51.9K | 0.26% | 76 |
|
|
2022
Q2 | $347K | Buy |
2,266
+602
| +36% | +$92.2K | 0.26% | 94 |
|
|
2022
Q1 | $270K | Buy |
1,664
+187
| +13% | +$30.3K | 0.18% | 117 |
|
|
2021
Q4 | $200K | Buy |
+1,477
| New | +$200K | 0.14% | 138 |
|